abstract |
A combination comprising: (a) a corticosteroid and (b) a muscarinic M3 receptor antagonist that is 3 (R) -1-phenethyl-3- (9H-xanthene-9-carbonyloxy) -1-azoniabicyclo [2.2. 2] octane, in the form of a salt having an X anion, which is a pharmaceutically acceptable anion of a mono- or polyvalent acid. |